Manufacturing facility news in brief
May 8, 2013Manufacturing and Production Expeditors, Novo Nordisk, Penn Pharma, Sagent Pharma, Vertellus
A round-up of new facility developments in the pharma sector, including updates from Novo Nordisk, Sagent, Penn Pharma, Vertellus and …
VBP will be ‘unfair’: report
May 8, 2013Medical Communications, Research and Development, Sales and Marketing 2020health, ABPI, NHS, VBP
A new report on value-based pricing (VBP) concludes that the new system will be unfair to patients and says the …
AstraZeneca reveals Alderley Park plan
May 8, 2013Research and Development, Sales and Marketing AstraZeneca, BioCity, R&D, alderley
AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …
New UK head at Porter Novelli
May 8, 2013Medical Communications, Sales and Marketing Porter Novelli, smiddy
PR firm Porter Novelli has announced that Mary Smiddy has been named as its new UK head of health & …
Asian regulators take issue with J&J facilities
May 7, 2013Manufacturing and Production India, J&J, JJ, Korea, inspection
Johnson & Johnson’s manufacturing network is under yet more scrutiny following regulatory actions by authorities in India and South Korea. …
Funding boost for GSK open lab
May 7, 2013Research and Development, Sales and Marketing GSK, Wellcome
GlaxoSmithKline has been given an extra £5 million by the Wellcome Trust to help support its work in Spain on …
Lessons from the business gurus
May 7, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, buffet, business gurus
Marketing books are full of pithy quotes from business gurus, quotes which are often repeated until they almost become mantras. …
FleishmanHillard appoints two directors
May 7, 2013Medical Communications, Sales and Marketing FleishmanHillard
Comms firm FleishmanHillard has added two directors to its Healthcare leadership team. Robert Hanvik and Alison Wright have joined the …
FDA approves Liptruzet
May 7, 2013Sales and Marketing FDA, Merck, liptruzet
Merck is celebrating after its once-daily anti-cholesterol pill Liptruzet was approved by US regulators, expanding its indications. The drug – …
Teva says US facility will close in cost-cutting drive
May 3, 2013Manufacturing and Production Teva, closure, cuts
Teva has said it will shut down a manufacturing and R&D facility in Pennsylvania by 2017, with the loss of …
Sanofi’s performance dives
May 3, 2013Sales and Marketing Q1, Sanofi
Sanofi suffered a grim first three months of 2013, with sales dipping and profit plummeting as loss of exclusivity took …
Sanofi appoints two executive members
May 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, executive
Sanofi has announced a new commercial organisation which results in the appointment of two executives. Following the retirement of Hanspeter …
Lundbeck moves ahead in Q1
May 3, 2013Sales and Marketing Lexapro, Lundbeck, Otsuka, Q1
Lundbeck’s sales and profit increase in the first three months of 2013 was due largely to one-off payments it received, …
FDA seeks manufacturing data for GSK’s trametinib
May 2, 2013Manufacturing and Production FDA, GSK, melanoma
GlaxoSmithKline’s melanoma drug candidate trametinib has been delayed in the US by an FDA request for more information on its …
Boehringer and OBT in cancer tie-up
May 2, 2013Research and Development, Sales and Marketing Boehringer, Cancer, OBT
Boehringer Ingelheim and UK biotech firm Oxford BioTherapeutics (OBT) have signed a deal to discover novel antibody targets in cancer. …
Court rules against EMA disclosure
May 2, 2013Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Roche, transparency
The European Medicines Agency (EMA) has been ordered in an interim ruling by the General Court of the European Union …
Not-for-profit comms agency adds special advisor
May 1, 2013Medical Communications, Sales and Marketing Comprehensive communications
A new not-for-profit marketing and comms consultancy that specialises in healthcare and research has added Professor Martin Gibson to its …
GSK abandons Parkinson’s drug
May 1, 2013Research and Development, Sales and Marketing GSK, IPX066, Parkinson's
GlaxoSmithKline has terminated its three-year old agreement with Impax Pharmaceuticals to develop investigational Parkinson’s disease drug IPX066. “The decision has …
Manufacturing issues block Gilead approvals
May 1, 2013Manufacturing and Production FDA, Gilead
The FDA has blocked approval of two of Gilead Sciences’ HIV drugs because of deficiencies in their marketing applications related …
Life appoints new executive
May 1, 2013Medical Communications, Sales and Marketing Anderson, Life
Creative comms agency Life Healthcare Communications has appointed a new account executive as part of the expansion of its client …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
